Avadel Pharmaceuticals plc (NASDAQ:AVDL) hits a 10-year high, with stock soaring 22.45% on Friday. The company received a new acquisition proposal from H Lundbeck A/S worth $23 per share, trumping Alkermes PLC’s bid. Avadel can consider other buyers but must honor current merger agreement with Alkermes.

Read more at Yahoo Finance: Avadel (AVDL) Soars to 10-Year High on Brewing Bidding War